Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KZR stock hub

Kezar Life Sciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KZRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

53.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KZR

In the news

Latest news · KZR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-59.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-31.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KZR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001645666
Company name	Kezar Life Sciences, Inc.
Country	United States
Country code	US
Cusip	49372L100
Employees	9
Employees Change	-46%
Employees Change Percent	-83.64
Enterprise value	$-15.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-06-21
Isin	US49372L2097
Last refreshed	2026-05-10
Market cap	$53.9M
Market cap category	Micro-Cap
Price	$7.29
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	KZR
Website	https://www.kezarlifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-104.04%
FCF yield	-96.15%
P/B ratio	0.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-33.8M
Net Income	$-56M
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Profit Per Employee	$-6.2M
ROA	-29.52
Roa5y	-24.18
ROCE	-74.59
ROE	-59.93
Roe5y	-44.21
ROIC	-31.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	78.75%
Cagr3y	-34.87%
Cagr5y	-33.49%
EPS Growth Quarters	8
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$76.6M
Cash	$71.9M
Current Assets	$75.7M
Current Liabilities	$6.6M
Debt	$2.3M
Debt Equity	$0.03
Equity	$70.1M
Interest Coverage	-58.08
Liabilities	$6.6M
Long Term Assets	$915,000
Long Term Liabilities	$0
Net Cash	$69.6M
Net Cash By Market Cap	$129
Net Cash Growth	-40.07%
Net Debt Equity	$-0.99
Tangible Book Value	$70.1M
Tangible Book Value Per Share	$9.56
WACC	7.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.52
Net Working Capital	$-394,000
Quick ratio	11.23
Working Capital	$69.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.37%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	78.68%
200-day SMA	5.79
3Y total return	-72.39%
50-day SMA	7.12
50-day SMA vs 200-day SMA	50over200
5Y total return	-86.98%
All Time High	363.3
All Time High Change	-97.99%
All Time High Date	2018-12-13
All Time Low	3.53
All Time Low Change	106.34%
All Time Low Date	2025-10-07
ATR	0.14
Beta	0.41
Beta1y	0.73
Beta2y	0.95
Ch YTD	15.9
High	7.47
High52	7.55
High52 Date	2026-04-02
High52ch	-3.44%
Low	7.27
Low52	3.53
Low52 Date	2025-10-07
Low52ch	106.34%
Ma50ch	2.43%
Price vs 200-day SMA	25.82%
RSI	52.55
RSI Monthly	40.55
RSI Weekly	66.04
Sharpe ratio	1.09x
Sortino ratio	3.18
Total Return	-0.37%
Tr YTD	15.9
Tr1m	-1.35%
Tr1w	-0.55%
Tr3m	19.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$5
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.98
Earnings Revenue Estimate	333,330x
Operating Income	$-52.3M
Price target	$6
Price Target Change	$-17.7
Price Target Change Top	$-31.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,174,606%
Float Percent	70.04%
Net Borrowing	-10,650,000
Shares Insiders	2.15%
Shares Institutions	47.41%
Shares Out	7,387,701
Shares Qo Q	0.06%
Shares Yo Y	0.37%
Short Float	2.93%
Short Ratio	1.31
Short Shares	2.05

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-60.7M
Average Volume	127,530.9x
Bv Per Share	9.56
CAPEX	$-8,000
Ch1m	-1.35
Ch1w	-0.55
Ch1y	78.68
Ch3m	19.12
Ch3y	-72.39
Ch5y	-86.98
Ch6m	20.7
Change	-0.95%
Change From Open	-0.95
Close	7.36
Days Gap	0
Depreciation Amortization	897,000
Dollar Volume	4,490,720.2
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-52.3M
EBITDA	$-51.4M
EPS	$-7.66
F Score	2
FCF	$-51.8M
FCF EV Yield	329.93x
FCF Per Share	$-7.01
Financing CF	-10,585,000
Fiscal Year End	December
Founded	2,015
Investing CF	92,463,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Last Split Date	2024-10-30
Last Split Type	Reverse
Last10k Filing Date	2026-03-27
Ma150	6.4
Ma150ch	13.84%
Ma20	7.33
Ma20ch	-0.57%
Net CF	30,129,000
Next Earnings Date	2026-05-22
Open	7.36
Optionable	Yes
Position In Range	10
Post Close	7.29
Postmarket Change Percent	1.1
Postmarket Price	$7.37
Ppne	915,000
Price Date	2026-05-08
Ptbv Ratio	0.77
Relative Volume	4.83x
Share Based Comp	8,963,000
Tr6m	20.7%
Us State	California
Volume	616,011

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KZR pay a dividend?

Capital-return profile for this ticker.

Performance

KZR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KZR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+47.4%

Float: +70.0% of shares outstanding

Insider ownership

+2.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

KZR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.5

Neutral momentum band

Price vs 200-day MA

+25.8%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

1.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KZR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current KZR stock rating?

Kezar Life Sciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full KZR analysis?

The full report lives at /stocks/KZR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for KZR?

The latest report frames KZR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the KZR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.